Previous Article | Next Article 
Infection and Immunity, August 2000, p. 4811-4814, Vol. 68, No. 8
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Pseudomonas aeruginosa Exoenzyme S
Induces Transcriptional Expression of Proinflammatory Cytokines
and Chemokines
Slava
Epelman,1
Tony F.
Bruno,1
Graham G.
Neely,2
Donald E.
Woods,1 and
Christopher H.
Mody1,3,*
Department of Microbiology and Infectious
Diseases,1 Department of Medical
Sciences,2 and Department of
Internal Medicine,3 University of Calgary,
Calgary, Alberta T2N 4N1, Canada
Received 6 March 2000/Returned for modification 20 April
2000/Accepted 15 May 2000
 |
ABSTRACT |
Pseudomonas aeruginosa infection of cystic fibrosis
patients causes lung damage that is substantially orchestrated by
cytokines. In this study, multi-gene probe analysis was used to
characterize the ability of the P. aeruginosa
mitogen, exoenzyme S, to induce proinflammatory and
immunoregulatory cytokines and chemokines. Exoenzyme S strongly induced
transcription of proinflammatory cytokines and chemokines (tumor
necrosis factor alpha, interleukin-1
[IL-1
], IL-1
, IL-6,
IL-8, MIP-1
, MIP-1
, MCP-1, RANTES, and I-309), modest
transcription of immunoregulatory cytokines (IL-10 and IL-12p40), and
weak transcription of Th1 cytokines (IL-2 and gamma interferon).
The response occurred early and subsided without evolving over time.
These data suggest that cells responding to exoenzyme S
would rapidly express proinflammatory cytokines and chemokines that may contribute to pulmonary inflammation in
cystic fibrosis.
 |
TEXT |
Virtually all cystic fibrosis (CF)
patients are colonized by Pseudomonas aeruginosa, and 90%
of those that are colonized die as a result of lung damage
(11). One of the hallmarks of the lung damage in CF is an
ineffective inflammatory response that results in severe
neutrophil-mediated pulmonary damage and an inability to clear the
organisms. P. aeruginosa contributes to the lung damage by
the production of virulence factors; one of the most important
virulence factors, exoenzyme S, has been shown to induce
pulmonary damage in animal models (17, 29, 35), and
increased levels of exoenzyme S correlate with human disease (18, 36). The cytotoxicity of exoenzyme S for
epithelial cells follows both contact-dependent type III translocation
into eukaryotic target cells and contact-independent type III
secretion, suggesting two mechanisms of cellular activation:
intracellular and extracellular (15, 34, 35). We have
recently described an additional activity: extracellular
exoenzyme S is mitogenic for T cells, inducing tremendous T-cell activation (5-7). Exoenzyme-S-induced activation of
T cells is neither dependent upon nor inhibited by
ADP-ribosyltransferase activity, and this activity is present in
exoenzyme S from both purified and recombinant sources
(7). Further, we have found that activation by
exoenzyme S induces T-cell apoptosis (6). The current studies were performed to determine whether this T-cell activation culminates in the induction of cytokines that have the
potential of influencing immunoinflammatory responses or whether apoptosis precludes cytokine transcription.
Immunoinflammatory responses are orchestrated by cytokines, and T-cell
mitogens and superantigens are potent stimuli for cytokine production
from T cells, monocytes, and macrophages (2, 3). In CF there
is a misdirected or dysregulated response, since there is a chronic and
exuberant immunoinflammatory response without clearance of the
pathogen. This response may be a result of altered cytokine induction
that includes decreased secretion of the anti-inflammatory cytokine
interleukin-10 (IL-10) (13, 28) with concordant increases in
proinflammatory cytokine production, including tumor necrosis factor
alpha (TNF-
), IL-1
, IL-1
, IL-6, and IL-8 (4, 11, 22). T-cell mitogens induce the production of many cytokines and
are capable of altering or polarizing the Th1 and Th2 cytokine profile,
which can have a potential pathogenic role during infection (8, 9,
14, 16, 31). We hypothesized that exoenzyme S could
contribute to a dysregulated immune response by the exaggerated production of both Th1 and Th2 cytokines and proinflammatory cytokines.
Cytokine effects and interactions are complex, with many cytokines
influencing the production of others throughout the time course of the
response. Because of this, multiparameter technology has been applied
to cytokine work (24) with the goal of determining the
kinetics of induction and the nature of the most important cytokine
response. For this purpose, the RNase protection assay (RPA) has
significant advantages; it is a sensitive and quantitative measure of
cytokine and chemokine mRNA induction that allows for the simultaneous
determination of multiple genes. Three gene panels were used to examine
transcriptional expression of Th1 and Th2 cytokines, proinflammatory
and immunoregulatory cytokines, and chemokines.
Exoenzyme S purification.
ExoS/DG1 from P. aeruginosa strain DG1 was isolated as previously described
using (NH4)2SO4 precipitation of
culture supernatants, ion-exchange chromatography, and acetone
precipitation, followed by gel filtration, and migrated as a 50-kDa
band without ADP-ribosyltransferase activity (35). rExoS was
isolated from Escherichia coli BL21(DE3) bearing a
plasmid encoding histidine-tagged exoenzyme S cloned from
P. aeruginosa 388(pETrHisExoS). rExoS was purified
by Ni2+ affinity chromatography from cellular lysates
and migrated as a 52-kDa band possessing ADP-ribosyltransferase
activity (7, 21). Neutralizing antibodies generated
against ExoS/DG1 were shown to neutralize T-cell activation induced by
rExoS, indicating that both preparations share the mitogenic epitope
(7).
Cell culture and RPA.
Peripheral blood mononuclear cell(s)
(PBMC) were isolated from healthy adults by Ficoll-Hypaque
density centrifugation (27). Cells (2 × 105 cells/well) were cultured in AIM V serum free
medium (Gibco BRL, Burlington, Ontario, Canada) in 24-well nonadherent
plates (Costar) in the presence of 10 µg of polymyxin B per ml in
order to exclude cellular activation from lipopolysaccharides
(LPS) (30). Resting PBMC were stimulated with 1 µg
of either ExoS/DG1 or rExoS per ml.
At various times, PBMC were collected, and total RNA was extracted
(Qiagen, Inc., Mississauga, Ontario, Canada). RNA probes (PharMingen,
Mississauga, Ontario, Canada) to cytokines and chemokines were
radiolabeled with 35S and hybridized overnight to 3.5 µg
of RNA. Each panel of probes included L32 and GAPDH
(glyceraldehyde-3-phosphate dehydrogenase), which are
constitutively expressed and served as internal controls for RNA
content. Following hybridization, single-stranded RNA was digested with
RNase A and RNase T1. Double-stranded RNA was extracted
and separated by electrophoresis in a 5% polyacrylamide gel. Protected
fragments were visualized by autoradiography, and the intensity
of each band was quantified by exposure to a Phosphorimager screen and
calculated using ImageQuant software (Molecular Dynamics, Sunnyvake,
Calif.).
Th1 and Th2 cytokines.
T-cell mitogens and superantigens are
capable of altering or polarizing the Th1 or Th2 cytokine profile which
can have a significant role in the pathogenesis of infection (23,
26, 31). Since exoenzyme S is a T-cell mitogen, we
investigated whether T-cell cytokines were induced. A positive response
was defined as a >2-fold increase in the intensity compared to
unstimulated PBMC ([i.e., stimulated cytokine band
intensity/stimulated L32 band intensity]/[unstimulated cytokine band
intensity/unstimulated L32 band intensity]). Only those genes that
were detected are displayed in tabular form (Tables 1 and 2).
Neither ExoS/DG1 nor rExoS induced transcription of IL-4 or IL-5 (Fig.
1 and Table 1). Modest induction of Th1
type cytokines (IL-2 and gamma interferon [IFN-
]) was seen (Fig. 1 and Table 1), which was confirmed by reverse transcription-PCR (RT-PCR)
(data not shown). We were somewhat surprised by the relative lack of
induction, since exoenzyme S causes rapid expression of high
levels of CD69 on a large percentage of T cells, which reflects substantial activation (5, 7). By contrast, both ExoS/DG1 and rExoS strongly induced transcription of the proinflammatory cytokines IL-1
and IL-1
that peaked between 5 and 24 h and
declined after 5 days. Since strong induction of proinflammatory
cytokines and a vigorous inflammatory response characterize the
response in CF patients infected with P. aeruginosa
(11), this led us to hypothesize that exoenzyme S
preferentially induces proinflammatory cytokines. Thus, we examined the
ability of exoenzyme S to induce proinflammatory cytokines and
chemokines.

View larger version (113K):
[in this window]
[in a new window]
|
FIG. 1.
Preferential induction of Th1 cytokines from PBMC by
stimulation with exoenzyme S. Resting PBMC were either
unstimulated (U), stimulated with 1 µg of ExoS/DG1 per ml (D), or
stimulated with 1 µg of rExoS per ml (R) for various times.
Undigested fragments were used as markers to determine the identity of
protected fragments. Densitometric values are given in Table 1. The
experiment was repeated twice with similar results.
|
|
Proinflammatory cytokine induction by exoenzyme S.
Together with IL-1
and IL-1
, ExoS/DG1 and rExoS induced rapid
transcription of additional proinflammatory cytokines including TNF-
and IL-6 (Fig. 2A and Table 1). While
both TNF-
and IL-6 peaked at 5 h, transcription of IL-6
decreased significantly by day 1 and transcription of TNF-
decreased
gradually until day 5. The ExoS/DG1- and rExoS-induced cytokine profile
was indicative of a proinflammatory stimulus more so than a polarized
Th1-Th2 response with the induction of proinflammatory cytokines such as TNF-
, IL-1
, IL-1
, and IL-6. These cytokines mediate
inflammatory responses through a variety of mechanisms, including the
activation and recruitment of numerous cell types (9, 19).

View larger version (95K):
[in this window]
[in a new window]
|
FIG. 2.
Exoenzyme S induces transcription of proinflammatory
cytokine (A) and chemokine (B) mRNA. Resting PBMC were either
unstimulated (U), stimulated with 1 µg of ExoS/DG1 per ml (D), or
with 1 µg of rExoS per ml (R) for various times. Undigested fragments
were used as markers to determine the identity of protected fragments.
Densitometric values are given in Tables 1 and 2. The experiment was
repeated twice with similar results.
|
|
Both ExoS/DG1 and rExoS induced transcription of all of the chemokines
tested (Fig.
2B). Transcription of IP-10, I-309, MIP-1

,
and
MIP-1

peaked at 5 h, and transcription of RANTES,
MCP-1,
and IL-8 peaked after 1 day of stimulation (Fig.
2B and Table
2). Ltn induction by both ExoS/DG1 and rExoS was weak (Fig.
2B
and
Table
2). Chemokine responses declined to near baseline levels
by day
5. Based on mRNA expression, it would be predicted that
neutrophils,
monocytes, and T cells would be recruited to the
lung. IL-8 and
MIP-1

induce neutrophil chemotaxis, and neutrophil
infiltration is
believed to be responsible for neutrophil-mediated
pulmonary tissue
damage in CF (
4,
11,
12). In addition
to neutrophil
recruitment, exoenzyme-S-induced MCP-1, IP-10, MIP-1

,
MIP-1

, and RANTES are capable of recruiting monocytes to the
lung (
9,
38). The time course of transcription of all of
the
cytokines and chemokines was similar. There was no evidence
of late
transcription of some cytokines and therefore no suggestion
that the
response would evolve with time, with early recruitment
of some cell
types and late recruitment of other cells, or with
a change in the
activation state of these cells. This may be because
apoptosis
intercedes and abrogates late cytokine
responses.
Cytokine and chemokine induction by exoenzyme S may play a key
role in the deficient cell-mediated immunity observed in CF
patients
(
32). I-309, RANTES, IL-8, MIP-1

, MIP-1

, and Ltn
are chemotactic for T cells (
9). The ability of
exoenzyme-S-recruited
T cells to mount a protective immune
response may be altered by
both direct and indirect mechanisms.
Exoenzyme S induces apoptosis
of T cells and, although the
mechanism of this apoptosis has not
yet been determined
(
6), it is possible that activated monocytes
induce
the death of T cells through a TNF-

-dependent mechanism
(
1), which would be an important mechanism of T-cell
immunosuppression.
Immunoregulatory cytokines may also contribute to T-cell suppression.
IL-12p40 was induced by both ExoS/DG1 (11-fold induction)
and rExoS
(4-fold induction), as was IL-10, which are capable
of modulating
T-cell function (Fig.
1 and
2A and Table
1) (
9).
Biologically active IL-12p70 is composed of the IL-12p35/p40
heterodimer,
which induces IFN-

secretion from T cells and NK
cells and promotes
differentiation of Th1 cells (
9,
10).
Transcription of IL-12p40
mRNA was detected, although transcription of
IL-12p35 mRNA was
not (Fig.
2A). Induction of IL-12p40 without IL-12p35
is a potential
mechanism of altering the host response to
P. aeruginosa since
excess production of IL-12p40 can inhibit
IL-12p70 function, resulting
in decreased T-cell effector functions
(
25). This may be a potential
explanation for the minimal
transcription of IFN-

despite marked
T-cell activation by
exoenzyme S. Furthermore, IL-12p40 may also
contribute to the
inflammatory response by directly recruiting
monocytes (
20).
It is also noteworthy that, despite the transcription
of IL-10, which
regulates cytokines primarily at the level of
transcription,
substantial induction of proinflammatory cytokines
and chemokines was
present.
Polymyxin B was added to the cultures to eliminate any potential effect
of LPS. Although it was unlikely that LPS was contributing
when
polymyxin B was present, additional experiments were performed
to
ensure that polymyxin B was capable of blocking the effect
of any LPS
contamination. A more sensitive RT-PCR-based assay
(
33) was
used to amplify TNF-

mRNA, which is highly responsive
to minute
mounts of LPS (
37).
P. aeruginosa LPS (10 µg/ml) induced
strong TNF-

induction (Fig.
3). In the presence of polymyxin
B (10 µg/ml), LPS-induced TNF-

mRNA was abrogated, indicating
that
polymyxin B neutralized LPS. TNF-

mRNA that was induced
by ExoS/DG1
was not inhibited by polymyxin B, indicating that
the observed cytokine
induction was not due to contaminating LPS.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 3.
LPS contamination is not responsible for cytokine
upregulation. PBMC were stimulated in RPMI culture media for 3 h.
PBMC were either unstimulated (Unst), stimulated with 10 µg of
P. aeruginosa per ml (LPS), or stimulated with 1 µg
of ExoS/DG1 per ml (DG1) with or without 10 µg of polymyxin B per ml.
PBMC were collected and lysed, and the RNA was extracted. RT was
performed using random hexamer primers. PCR was performed for 26 cycles
using TNF- -specific and GAPDH-specific primers. The experiment was
repeated twice with similar results.
|
|
Increased levels of TNF-

, IL-8, IL-1

, IL-1

, and IL-6 and
relatively unchanged levels of IL-1RA in response to exoenzyme
S (Fig.
1 and
2) is a cytokine profile that is reminiscent of
that
found in the lungs of CF patients infected with
P. aeruginosa compared to healthy individuals (
4,
11,
22).
It is likely
that other proinflammatory cytokines also contribute to
the inflammation,
and certainly other cytokines are induced by
exoenzyme S, although
we are not aware of studies measuring
these cytokines in the CF
lung. We have observed that exoenzyme
S isolated from two different
strains of
P. aeruginosa
possess the ability to induce the transcription
of proinflammatory
cytokines and chemokines from PBMC, and this
effect is not dependent on
ADP-ribosyltransferase activity. Through
the characterization of the
cytokine-chemokine response of PBMC
to exoenzyme S, we have
identified a number of mechanisms by which
exoenzyme S may
contribute to ongoing pulmonary inflammation in
CF. Understanding the
mechanisms of an exoenzyme-S-induced inflammatory
response will
lead to a greater understanding of host-pathogen
interactions and may
help us devise immunotherapeutic strategies
designed to alleviate
P. aeruginosa-mediated inflammation in CF
patients.
 |
ACKNOWLEDGMENTS |
This work was supported by a grant from the Canadian Cystic
Fibrosis Foundation.
We would like to thank Joseph Barbieri for his kind gift of the
pETrHisExoS vector and Howard Wong for his expertise in RT-PCR.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Heritage Medical
Research Building, Rm. 273, 3330 Hospital Dr., N.W., University of Calgary, Calgary, Alberta, Canada T2N-4N1. Phone: (403) 220-8479. Fax:
(403) 270-2772. E-mail: cmody{at}ucalgary.ca.
Editor:
E. I. Tuomanen
 |
REFERENCES |
| 1.
|
Badley, A. D.,
D. Dockrell,
M. Simpson,
R. Schut,
D. H. Lynch,
P. Leibson, and C. V. Paya.
1997.
Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor.
J. Exp. Med.
185:55-64[Abstract/Free Full Text].
|
| 2.
|
Beharka, A. A.,
J. J. Iandolo, and S. K. Chapes.
1995.
Staphylococcal enterotoxins bind H-2Db molecules on macrophages.
Proc. Natl. Acad. Sci. USA
92:6294-6298[Abstract/Free Full Text].
|
| 3.
|
Bjork, L.,
J. Andersson,
M. Ceska, and U. Andersson.
1992.
Endotoxin and Staphylococcus aureus enterotoxin A induce different patterns of cytokines.
Cytokine
4:513-519[CrossRef][Medline].
|
| 4.
|
Bonfield, T. L.,
J. R. Panuska,
M. W. Konstan,
K. A. Hilliard,
J. B. Hilliard,
H. Ghnaim, and M. Berger.
1995.
Inflammatory cytokines in cystic fibrosis lungs.
Am. J. Respir. Crit. Care Med.
152:2111-2118[Abstract].
|
| 5.
|
Bruno, T. F.,
D. E. Buser,
R. M. Syme,
D. E. Woods, and C. H. Mody.
1998.
Pseudomonas aeruginosa exoenzyme S is a mitogen but not a superantigen for human T lymphocytes.
Infect. Immun.
66:3072-3079[Abstract/Free Full Text].
|
| 6.
| Bruno, T. F., D. E. Woods, and C. H. Mody. Exoenzyme S induces apoptosis of T lymphocytes.
J. Leukoc. Biol., in press.
|
| 7.
|
Bruno, T. F.,
D. E. Woods,
D. G. Storey, and C. H. Mody.
1999.
Recombinant Pseudomonas exoenzyme S and exoenzyme S from Pseudomonas aeruginosa strain DG1 share the ability to stimulate T lymphocyte proliferation.
Can. J. Microbiol.
45:607-611[CrossRef][Medline].
|
| 8.
|
Carding, S. R.,
J. West,
A. Woods, and K. Bottomly.
1989.
Differential activation of cytokine genes in normal CD4-bearing T cells is stimulus dependent.
Eur. J. Immunol.
19:231-238[Medline].
|
| 9.
|
Curfs, J. H. A. J.,
J. F. G. M. Meis, and J. A. A. Hoogkamp-Korstanje.
1997.
A primer on cytokines: sources, receptors, effects, and inducers.
Clin. Microbiol. Rev.
10:742-780[Abstract].
|
| 10.
|
D'Andrea, A.,
M. Rengaraju,
N. M. Valiante,
J. Chemimi,
M. Kubin,
M. Aste,
S. H. Chan,
M. Kobayashi,
D. Young,
E. Nickbarg,
R. Chizzonite,
S. F. Wolf, and G. Trinchieri.
1992.
Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.
J. Exp. Med.
176:1387-1398[Abstract/Free Full Text].
|
| 11.
|
Davis, P. B.,
M. Drumm, and M. W. Konstan.
1996.
Cystic fibrosis.
Am. J. Respir. Crit. Care Med.
154:1229-1256[Medline].
|
| 12.
|
Dayer Pastore, F.,
S. E. Schlegel-Haueter,
D. C. Belli,
T. Rochat,
T. S. Dudez, and S. Suter.
1998.
Chemotactic factors in bronchial secretions of cystic fibrosis patients.
J. Infect. Dis.
177:1413-1417[Medline].
|
| 13.
|
Dosanjh, A. K.,
D. Elashoff, and R. C. Robbins.
1998.
The bronchoalveolar lavage fluid of cystic fibrosis lung transplant recipients demonstrates increased interleukin-8 and elastase and decreased IL-10.
J. Interferon Cytokine Res.
18:851-854[Medline].
|
| 14.
|
Firestein, G. S.,
W. D. Roeder,
J. A. Laxer,
K. S. Townsend,
C. T. Weaver,
J. T. Hom,
J. Linton,
B. E. Torbett, and A. L. Glasebrook.
1989.
A new murine CD4+ T cell subset with an unrestricted cytokine profile.
J. Immunol.
143:518-525[Abstract].
|
| 15.
|
Frank, D. W.
1997.
The exoenzyme S regulon of Pseudomonas aeruginosa.
Mol. Microbiol.
26:621-629[CrossRef][Medline].
|
| 16.
|
Gantner, F.,
M. Leist,
S. Kusters,
K. Vogt,
H. D. Volk, and G. Tiegs.
1996.
T cell stimulus-induced crosstalk between lymphocytes and liver macrophages results in augmented cytokine release.
Exp. Cell Res.
229:137-146[CrossRef][Medline].
|
| 17.
|
Grimwood, K.,
M. To,
H. R. Rabin, and D. E. Woods.
1989.
Subinhibitory antibiotics reduce Pseudomonas aeruginosa tissue injury in the rat lung model.
J. Antimicrob. Chemother.
24:937-945[Abstract/Free Full Text].
|
| 18.
|
Grimwood, K.,
M. To,
R. A. Semple,
H. R. Rabin,
P. A. Sokol, and D. E. Woods.
1993.
Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis.
Pediatr. Pulmonol.
15:135-139[Medline].
|
| 19.
|
Guidot, D. M.,
B. M. Hybertson,
R. P. Kitlowski, and J. E. Repine.
1996.
Inhaled NO prevents IL-1-induced neutrophil accumulation and associated acute edema in isolated rat lungs.
Am. J. Physiol.
271:L225-L229[Abstract/Free Full Text].
|
| 20.
|
Ha, S. J.,
C. H. Lee,
S. B. Lee,
C. M. Kim,
K. L. Jang,
H. S. Shin, and Y. C. Sung.
1999.
A novel function of IL-12p40 as a chemotactic molecule for macrophages.
J. Immunol.
163:2902-2908[Abstract/Free Full Text].
|
| 21.
|
Knight, D. A.,
V. Finck-Barbancon,
S. M. Kulich, and J. T. Barbieri.
1995.
Functional domains of Pseudomonas aeruginosa exoenzyme S.
Infect. Immun.
63:3182-3186[Abstract].
|
| 22.
|
Kronborg, G.,
M. B. Hansen,
M. Svenson,
A. Fomsgaard,
N. Hoiby, and K. Bendtzen.
1993.
Cytokines in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs.
Pediatr. Pulmonol.
15:292-297[Medline].
|
| 23.
|
Kuge, S.,
Y. Miura,
Y. Nakamura,
T. Mitomi,
S. Habu, and T. Nishimura.
1995.
Superantigen-induced human CD4+ helper/killer T cell phenomenon. Selective induction of Th1 helper/killer T cells and application to tumor immunotherapy.
J. Immunol.
154:1777-1785[Abstract].
|
| 24.
|
Luo, Y.,
C. Lloyd,
J. C. Gutierrez-Ramos, and M. E. Dorf.
1999.
Chemokine amplification in mesangial cells.
J. Immunol.
163:3985-3992[Abstract/Free Full Text].
|
| 25.
|
Mattner, F.,
S. Fischer,
S. Guckes,
S. Jin,
H. Kaulen,
E. Schmitt,
E. Rude, and T. Germann.
1993.
The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer.
Eur. J. Immunol.
23:2202-2208[Medline].
|
| 26.
|
Miethke, T.,
C. Wahl,
K. Heeg, and H. Wagner.
1992.
T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor.
J. Exp. Med.
175:91-98[Abstract/Free Full Text].
|
| 27.
|
Mody, C. H.,
D. E. Buser,
R. M. Syme, and D. E. Woods.
1995.
Pseudomonas aeruginosa exoenzyme S induces proliferation of human T lymphocytes.
Infect. Immun.
63:1800-1805[Abstract].
|
| 28.
|
Moss, R. B.,
R. C. Bocian,
Y. P. Hsu,
Y. J. Dong,
M. Kemna,
T. Wei, and P. Gardner.
1996.
Reduced IL-10 secretion by CD4+ T lymphocytes expressing mutant cystic fibrosis transmembrane conductance regulator (CFTR).
Clin. Exp. Immunol.
106:374-388[CrossRef][Medline].
|
| 29.
|
Nicas, T. I.,
D. W. Frank,
J. D. Lile, and B. H. Iglewski.
1985.
Role of exoenzyme S in chronic Pseudomonas aeruginosa lung infections.
Eur. J. Clin. Microbiol.
4:175-179[CrossRef][Medline].
|
| 30.
|
Ofek, I.,
S. Cohen,
R. Rahmani,
K. Kabha,
D. Tamarkin,
Y. Herzig, and E. Rubinstein.
1994.
Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental gram-negative infections in mice.
Antimicrob. Agents Chemother.
38:374-377[Abstract/Free Full Text].
|
| 31.
|
Rink, L.,
J. Luhm,
M. Koester, and H. Kirchner.
1996.
Induction of a cytokine network by superantigens with parallel Th1 and Th2 stimulation.
J. Interferon Cytokine Res.
16:41-47[Medline].
|
| 32.
|
Sorensen, R. U.,
R. C. Stern, and S. H. Polmar.
1977.
Cellular immunity to bacteria: impairment of in vitro lymphocyte responses to Pseudomonas aeruginosa in cystic fibrosis patients.
Infect. Immun.
18:735-740[Abstract/Free Full Text].
|
| 33.
|
Syme, R. M.,
C. J. Wood,
H. Wong, and C. H. Mody.
1997.
Both CD4+ and CD8+ human lymphocytes are activated and proliferate in response to Cryptococcus neoformans.
Immunology
92:194-200[CrossRef][Medline].
|
| 34.
|
Vallis, A. J.,
T. L. Yahr,
J. T. Barbieri, and D. W. Frank.
1999.
Regulation of ExoS production and secretion by Pseudomonas aeruginosa in response to tissue culture conditions.
Infect. Immun.
67:914-920[Abstract/Free Full Text].
|
| 35.
|
Woods, D. E., and J. U. Que.
1987.
Purification of Pseudomonas aeruginosa exoenzyme S.
Infect. Immun.
55:579-586[Abstract/Free Full Text].
|
| 36.
|
Woods, D. E.,
M. S. Schaffer,
H. R. Rabin,
G. D. Campbell, and P. A. Sokol.
1986.
Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical isolates.
J. Clin. Microbiol.
24:260-264[Abstract/Free Full Text].
|
| 37.
|
Wright, S. D.,
R. A. Ramos,
P. S. Tobias,
R. J. Ulevitch, and J. C. Mathison.
1990.
CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.
Science
249:1431-1433[Abstract/Free Full Text].
|
| 38.
|
Wuyts, A.,
P. Proost,
W. Put,
J. P. Lenaerts, and J. Van Damme.
1994.
Leukocyte recruitment by monocyte chemotactic proteins (MCPs) secreted by human phagocytes.
J. Immunol. Rev.
174:237-247.
|
Infection and Immunity, August 2000, p. 4811-4814, Vol. 68, No. 8
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Venza, I., Cucinotta, M., Visalli, M., De Grazia, G., Oliva, S., Teti, D.
(2009). Pseudomonas aeruginosa Induces Interleukin-8 (IL-8) Gene Expression in Human Conjunctiva through the Recruitment of Both RelA and CCAAT/Enhancer-binding Protein {beta} to the IL-8 Promoter. J. Biol. Chem.
284: 4191-4199
[Abstract]
[Full Text]
-
Epelman, S., Berenger, B., Stack, D., Neely, G. G., Ma, L. L., Mody, C. H.
(2008). Microbial Products Activate Monocytic Cells through Detergent-Resistant Membrane Microdomains. Am. J. Respir. Cell Mol. Bio.
39: 657-665
[Abstract]
[Full Text]
-
Cuzick, A., Stirling, F. R., Lindsay, S. L., Evans, T. J.
(2006). The Type III Pseudomonal Exotoxin U Activates the c-Jun NH2-Terminal Kinase Pathway and Increases Human Epithelial Interleukin-8 Production. Infect. Immun.
74: 4104-4113
[Abstract]
[Full Text]
-
Epelman, S., Stack, D., Bell, C., Wong, E., Neely, G. G., Krutzik, S., Miyake, K., Kubes, P., Zbytnuik, L. D., Ma, L. L., Xie, X., Woods, D. E., Mody, C. H.
(2004). Different Domains of Pseudomonas aeruginosa Exoenzyme S Activate Distinct TLRs. J. Immunol.
173: 2031-2040
[Abstract]
[Full Text]
-
Divangahi, M., Matecki, S., Dudley, R. W. R., Tuck, S. A., Bao, W., Radzioch, D., Comtois, A. S., Petrof, B. J.
(2004). Preferential Diaphragmatic Weakness during Sustained Pseudomonas aeruginosa Lung Infection. Am. J. Respir. Crit. Care Med.
169: 679-686
[Abstract]
[Full Text]
-
McMorran, B., Town, L., Costelloe, E., Palmer, J., Engel, J., Hume, D., Wainwright, B.
(2003). Effector ExoU from the Type III Secretion System Is an Important Modulator of Gene Expression in Lung Epithelial Cells in Response to Pseudomonas aeruginosa Infection. Infect. Immun.
71: 6035-6044
[Abstract]
[Full Text]
-
Lagoumintzis, G., Christofidou, M., Dimitracopoulos, G., Paliogianni, F.
(2003). Pseudomonas aeruginosa Slime Glycolipoprotein Is a Potent Stimulant of Tumor Necrosis Factor Alpha Gene Expression and Activation of Transcription Activators Nuclear Factor {kappa}B and Activator Protein 1 in Human Monocytes. Infect. Immun.
71: 4614-4622
[Abstract]
[Full Text]
-
Jendrossek, V., Fillon, S., Belka, C., Muller, I., Puttkammer, B., Lang, F.
(2003). Apoptotic Response of Chang Cells to Infection with Pseudomonas aeruginosa Strains PAK and PAO-I: Molecular Ordering of the Apoptosis Signaling Cascade and Role of Type IV Pili. Infect. Immun.
71: 2665-2673
[Abstract]
[Full Text]
-
Wei, B., Huang, T., Dalwadi, H., Sutton, C. L., Bruckner, D., Braun, J.
(2002). Pseudomonas fluorescens Encodes the Crohn's Disease-Associated I2 Sequence and T-Cell Superantigen. Infect. Immun.
70: 6567-6575
[Abstract]
[Full Text]
-
CANT, A.J., GORDON, S.B., READ, R.C., HART, C.A., WINSTANLEY, C.
(2002). Respiratory infections: Proceedings of the Eighth Liverpool Tropical School Bayer Symposium of Microbial Disease held on 3 February 2001. J Med Microbiol
51: 903-914
[Full Text]
-
Thakur, A., Xue, M., Stapleton, F., Lloyd, A. R., Wakefield, D., Willcox, M. D. P.
(2002). Balance of Pro- and Anti-Inflammatory Cytokines Correlates with Outcome of Acute Experimental Pseudomonas aeruginosa Keratitis. Infect. Immun.
70: 2187-2197
[Abstract]
[Full Text]
-
Hart, C A., Winstanley, C.
(2002). Persistent and aggressive bacteria in the lungs of cystic fibrosis children. Br Med Bull
61: 81-96
[Abstract]
[Full Text]
-
Epelman, S., Neely, G. G., Ma, L. L., Gjomarkaj, M., Pace, E., Melis, M., Woods, D. E., Mody, C. H.
(2002). Distinct fates of monocytes and T cells directly activated by Pseudomonas aeruginosa exoenzyme S. J. Leukoc. Biol.
71: 458-468
[Abstract]
[Full Text]
-
Chensue, S. W.
(2001). Molecular Machinations: Chemokine Signals in Host-Pathogen Interactions. Clin. Microbiol. Rev.
14: 821-835
[Abstract]
[Full Text]